NYSE:MTD - Mettler-Toledo International Stock Price, Price Target & More

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International Inc. (NYSE:MTD) announced its quarterly earnings results on Thursday, May, 3rd. The medical instruments supplier reported $3.74 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $3.73 by $0.01. The medical instruments supplier earned $660.82 million during the quarter, compared to the consensus estimate of $651.87 million. Mettler-Toledo International had a net margin of 13.50% and a return on equity of 90.70%. The business's quarterly revenue was up 11.1% compared to the same quarter last year. During the same period last year, the firm earned $3.34 EPS. View Mettler-Toledo International's Earnings History.

Mettler-Toledo International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Mettler-Toledo International.

Mettler-Toledo International updated its second quarter earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $4.55 to $4.60 for the period, compared to the Thomson Reuters consensus estimate of $4.54.

10 equities research analysts have issued 12-month target prices for Mettler-Toledo International's shares. Their predictions range from $540.00 to $692.00. On average, they anticipate Mettler-Toledo International's share price to reach $628.00 in the next year. This suggests a possible upside of 9.1% from the stock's current price. View Analyst Ratings for Mettler-Toledo International.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Mettler-Toledo International include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

Media headlines about MTD stock have been trending somewhat positive on Monday, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Mettler-Toledo International earned a media sentiment score of 0.16 on Accern's scale. They also gave media stories about the medical instruments supplier an impact score of 43.72 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Mettler-Toledo International's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Welch & Forbes LLC (0.27%), Bank of Montreal Can (0.23%), Legacy Private Trust Co. (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%), Carderock Capital Management Inc. (0.03%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own Mettler-Toledo International stock include Christian Magloth, Francis A Contino, Hans Ulrich Maerki, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Richard D Francis, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Institutional Ownership Trends for Mettler-Toledo International.

MTD stock was sold by a variety of institutional investors in the last quarter, including Welch & Forbes LLC, Legacy Private Trust Co., State of Alaska Department of Revenue, CENTRAL TRUST Co, Gateway Investment Advisers LLC and Carderock Capital Management Inc.. Company insiders that have sold Mettler-Toledo International company stock in the last year include Christian Magloth, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Insider Buying and Selling for Mettler-Toledo International.

MTD stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, Xact Kapitalforvaltning AB and Atria Investments LLC. View Insider Buying and Selling for Mettler-Toledo International.

Shares of MTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MTD stock can currently be purchased for approximately $575.36.

Mettler-Toledo International has a market capitalization of $14.81 billion and generates $2.73 billion in revenue each year. The medical instruments supplier earns $375.97 million in net income (profit) each year or $17.57 on an earnings per share basis. Mettler-Toledo International employs 15,400 workers across the globe.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The medical instruments supplier can be reached via phone at 614-438-4511 or via email at [email protected]